NextPoint is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 checkpoint axis. Our innovative approach integrates foundational science with a defined clinical biomarker strategy to deliver a new class of monotherapies for patients who do not benefit from PD-1/L1 inhibitors. NextPoint is simultaneously advancing therapeutic approaches utilizing the unique upregulation of HHLA2 in cancer as an anchor for tumor-targeting therapeutic modalities. Our team of proven drug developers is working closely with our renowned scientific founders to launch a new world of precision immuno-oncology and beyond.
View Top Employees from NextPoint Therapeutics, Inc.Website | http://www.nextpointtx.com |
Employees | 41 (27 on RocketReach) |
Industry | Biotechnology |
Looking for a particular NextPoint Therapeutics, Inc. employee's phone or email?
Leena Gandhi is the Chief Medical Officer of NextPoint Therapeutics, Inc..
27 people are employed at NextPoint Therapeutics, Inc..